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Case-reportObjective: Transient loss of consciousness (T-LOC) can occur during transcranial magnetic stimulation
(TMS). T-LOC during TMS can be caused by syncope or seizure. TMS operators explicitly screen partici-
pants and are also able to witness clinical manifestations of T-LOC during stimulation. Therefore they
have direct access to information necessary to tell the two etiologies apart, if they are well trained on
the clinical differences and not only sensitive to the potential risk of seizure induction. We here present
a typical case of vasovagal syncope during TMS to contrast its clinical manifestations to that of seizures.
Method: We describe an event of T-LOC in a 21 year old healthy woman during single-pulse TMS.
Screening, setting, clinical manifestations and advanced diagnostics are reported.
Discussion: Based on the detailed description of the case, we discuss why syncope is the most parsimo-
nious etiology for the clinical picture observed in this participant. We provide information on typical clin-
ical features of seizure that were particularly not observed. We also address potential benefits of further
diagnostic tools. Additionally, we go into more parameters that can be useful to distinguish syncope from
seizure.
Conclusion: TMS operators should be well aware of the differentiation of T-LOC in syncopal or ictal in eti-
ology, because they witness T-LOC during TMS. By presenting a typical case of vasovagal syncope during
TMS the report in hand provides necessary information and literature to do so.
 2016 Published by Elsevier B.V. on behalf of International Federation of Clinical Neurophysiology. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).1. Introduction
Transient loss of consciousness (T-LOC) is difficult to classify as
syncopal or caused by seizure if it is not directly observed. Because
transcranial magnetic stimulation (TMS) is always performed in
the presence of an operator, T-LOC occurring during a stimulation
session is witnessed in most cases. Nevertheless, there are difficul-
ties in diagnosing the cause of T-LOC during TMS for several rea-
sons. First, because operators are often not medical practitioners
experienced in differentiating the two conditions (e.g., neurolo-
gists). Secondly, because operators are typically not explicitly
trained by physicians to distinguish syncope apart from seizure.
Instead, operators are often very sensitive to the potential risk of
seizure induction as the most severe, albeit relatively uncommon,side effect during repetitive TMS (rTMS). In order to manage an
occurrence of T-LOC appropriately, it is crucial to be aware of the
possibility of inducing a seizure during stimulation. That prior
knowledge itself, however, may result in a biased clinical classifica-
tion of the adverse event. In that regard, reports describing the
clinical picture of other causes of T-LOC, such as TMS-related syn-
cope, are rare (Hadar et al., 2012; Sczesny-Kaiser et al., 2013;
Gillick et al., 2015) and therefore awareness of this cause is low.
We here present a typical case of vasovagal syncope during TMS
to illustrate its clinical manifestations relative to that of seizures.2. Case report
2.1. Screening
The participant was a 21 year old healthy woman. A screening
questionnaire (Rossi et al., 2011) prior to participation in the
experiment revealed no exclusion criteria for TMS. In particular,
the participant did not take any medications that might lower
seizure threshold and denied any personal or family history of
P. Riedel et al. / Clinical Neurophysiology Practice 1 (2016) 58–61 59epileptic seizures. The participant reported three episodes of T-LOC
in the past that were classified as syncopal with high certainty (see
discussion below). A non-diagnostic, structural magnetic reso-
nance imaging scan one year prior to screening showed no pathol-
ogy, especially no intracranial space-occupying lesion. The
participant gave informed consent to this case report.2.2. Setting
The stimulation took place as part of a cognitive-
neuroscientific study that aimed at measuring behavior in a psy-
chological experimental task after transient disruption of a brain
area that is presumably involved in the cognitive process associ-
ated with the task. The experimental session was performed in a
TMS research laboratory in a non-clinical setting, that was
equipped with a MagProX100 stimulator (MagVenture, Hueckel-
hoven, Germany; CE-certificate 0543) and a medical chair that
the participant was seated in (Greiner, Pleidelsheim, Germany).
Two non-medical operators, trained and experienced with TMS
stimulation, and trained in first aid and the management of side
effects of TMS by a physician, were present. The session started
with a measurement of resting motor threshold according to
the Rossini-Rothwell method using a figure eight coil, standard
coil orientation (anterior-medial direction of induced current),
positioned over the left scalp and centered approximately 5 cm
lateral/2 cm anterior from the vertex (stimulation of the right
first dorsal interosseous muscle); biphasic single-pulses with at
least 5 s between pulses (Rossini et al., 1994; also cf. Tranulis
et al., 2006).2.3. Clinical manifestation of T-LOC
On the day of the event, the participant appeared in good con-
dition to the experimenters and reported well-being upon inquiry.
After two single pulses (at 55% and 53% stimulator output) the par-
ticipant reported that stimulation was different to what was
expected, but was willing to continue. After the third pulse (at
53% stimulator output) the participant asked to stop the stimula-
tion and subsequently had rapid loss of consciousness accompa-
nied by loss of muscle tone and upward eye deviation.
Stimulation was immediately terminated. The participant had no
urinary or fecal incontinence, no tongue biting and no other phys-
ical trauma. Medical advice was sought. Consciousness was
regained completely and spontaneously within 30–60 s. She was
oriented, showed adequate formal reasoning and had no retro-
grade amnesia. Vital signs were in normal range (blood-pressure
120/80 mmHg, heart-rate 72/min). The participant laid down with
her legs inclined. An emergency physician was contacted by the
medical technical assistants.2.4. Advanced diagnostics
The participant was transferred to the hospital after having
been seen by the emergency physician as a precautionary measure.
Physical and neurological examination, circulatory parameters,
routine blood samples and electrocardiography showed normal
results. Neither electroencephalography (EEG) nor neuroimaging
was performed. The participant was dismissed from the hospital
on the same day. Four days later a routine check-up at the general
practitioner revealed no abnormality. The Calgary Syncope Symp-
tom Score (Romme et al., 2009), which was additionally performed
at our institute, indicated the presence of vasovagal syncope with a
total point score of 3.3. Discussion
3.1. Screening
The participant reported a history of T-LOC, unrelated to TMS,
that was determined to be likely syncopal in etiology. Syncope is
not an exclusion criterion for TMS. Nevertheless, it should be con-
sidered that syncope may emerge again during TMS. This is likely
unrelated to the electrophysiological effects of TMS itself, but
rather due to the procedure-associated stress (e.g., anxiety due to
the knowledge of receiving a stimulation of the brain). Knowledge
of this circumstance is critical, because in contrast to other proce-
dures (e.g. blood sampling), T-LOC during TMS needs to be classi-
fied as syncopal or TMS-induced seizure.3.2. TMS parameters
In rTMS shorter inter-train intervals, longer train durations and/
or increased TMS frequency go along with increased risk of seizure
induction (see Table 3 in Rossi et al., 2009 for safety limits).
Although seizure induction is the most severe adverse event of
TMS, incidence of rTMS-induced seizure is extremely low, espe-
cially if participants have no neurological disorder and are not on
medication lowering seizure threshold (Rossi et al., 2009). Seizure
induction in a healthy individual by single-pulse TMS at 53% stim-
ulator output is extremely unlikely (also see Pascual-Leone et al.,
1993). To our knowledge, there is only one report that described
seizure induction by single-pulse TMS (Kratz et al., 2011) and diag-
nosis of seizure remains questionable for that case.3.3. Clinical manifestation
The case in hand is particularly suited to present typical clinical
manifestations of syncope in contrast to seizure, because the par-
ticipant not only experienced T-LOC during single-pulse TMS, but
also prior to participation in the experiment and therefore not
TMS-related. Medical history assessment revealed that all events
of T-LOC prior to TMS were preceded by malaise or associated with
emotion or orthostatic stress (i.e., prior to taking a blood sample
and after long standing, during a common cold and nocturnal mic-
turition and during the administration of an inoculation). After T-
LOC, consciousness was consistently regained within seconds.
These are all criteria in line with vasovagal syncope (Moya et al.,
2009). On the other hand, typical clinical signs of seizure in previ-
ous events of T-LOC were denied, such as tongue-biting (Brigo
et al., 2012), urinary incontinence (Brigo et al., 2013), prolonged
loss of consciousness (i.e. minutes, Jenssen et al., 2006) and postic-
tal state (disorientation, retrograde amnesia etc., Fisher and
Schachter, 2000). Reported episodes of T-LOC were not preceded
by sleep deprivation, flickering lights or intoxication (e.g. alcohol);
events that are considered as seizure triggers (Koepp et al., 2016).
For the current event of T-LOC during TMS, none of the above-
mentioned clinical manifestations of seizure were present. How-
ever, as in the reported previous case history, the event was pre-
ceded by slight malaise and mild anxiety as well as constricted
field of vision and a feeling of warmth (as retrospectively affirmed
by the participant and hence not directly accessible during the
event of T-LOC). In contrast to previous episodes, though, this time
T-LOC was directly witnessed. This is an important point, because
neurological/motor symptoms typically related to most seizure
types (Crompton and Berkovic, 2009) could be excluded this way.
These are specifically (i) (tonic-) clonic movements, that is, a phase
of tonic posturing (stiffening) and/or a phase of clonic jerking
(twitching) of the muscles, (ii) vocalisations and (iii) automatisms
(e.g., repetitive raising and lowering of an arm as well as head turn-
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usually not present during syncope. If nonetheless present, such
as in convulsive syncope, these motor symptoms are still preceded
by syncope-typical features (e.g. lightheadedness, pallor, diaphore-
sis; also see Romme et al., 2008), usually do not include clear clonic
features and are of short duration (<15 s) (da Silva, 2014). Upward
eye deviation as observed during T-LOC in this participant can be
classified as a symptom of syncope (Lempert and von Brevern,
1996).
3.4. Consideration of age and gender
Age can be an additional marker when distinguishing syncope
from seizure. Vasovagal syncope is associated with younger age
(Romme et al., 2008) while the incidence of epilepsy is lowest
between age 20 and 40. However, this criterion can only be used
to classify past T-LOC (prior to TMS), because previously reported
cases of seizures in TMS predominantly occurred in participants
within age 20–40. Additionally, this case report adds to the previ-
ous literature that only reports TMS-related syncope in female par-
ticipants (Figiel et al., 1998; Hadar et al., 2012; Sczesny-Kaiser
et al., 2013; Gillick et al., 2015). The reason for the predominance
of female gender remains speculative: Incidence of syncope is
slightly higher in women compared to men in some studies
(Romme et al., 2008), other authors report no effect of gender on
the incidence of syncope in the general population (da Silva,
2014). Many TMS studies in healthy subjects are actually per-
formed in men only. The predominance of female gender is also
true for case reports on TMS-related seizures.
3.5. Clinical assessment
Although the Calgary Syncope Symptom Score (Romme et al.,
2009) indicated the presence of vasovagal syncope, specificity of
the score is low. However, the use of scoring schemes (e.g. also,
Sheldon et al., 2002) can be beneficial in differentiating seizure
from syncope in T-LOC during TMS. Our participant was admitted
to the hospital. Note that we do not suggest that indiscriminate
admission of participants with T-LOC to the hospital is necessary,
but rather that medical advice should be sought, and a joint deci-
sion on further proceedings made based on the individual circum-
stances. In the current case of T-LOC operators were not
sufficiently sure to link the observed clinical manifestations to
either syncope or seizure. The emergency physician neither wit-
nessed the event of T-LOC, nor was he aware of the relative risk
of seizure induction by TMS. Those circumstances most likely
resulted in the admission of the participant to further overlook
the case. There was no significant concern that the event was ictal
in etiology. If there was high suspicion for an epileptic seizure, an
EEG would be indicated for the evaluation of a first T-LOC event,
would have management implications and could have been per-
formed with moderate yield even 24–48 h after the occurrence of
T-LOC, that is, after admission to the hospital (King et al., 1998;
Krumholz et al., 2007). Magnetic resonance imaging (MRI) should
be performed when suspecting T-LOC as ictal in etiology to further
aid diagnosis and treatment (King et al., 1998; Krumholz et al.,
2007). An MRI-scan acquired in a non-clinical study setting with-
out proper MRI sequences and long time before the event is not
sufficient in that regard for both reasons.4. Conclusion
In summary, the most parsimonious etiology of the case of T-
LOC presented here is vasovagal syncope. Screening, clinical man-
ifestation and clinical assessment yielded no significant concernthat the event of T-LOC was ictal in etiology. Note that an atonic
seizure or focal seizure with impairment of consciousness cannot
be ruled out entirely, but are very unlikely. The differential diagno-
sis of an absence seizure (as documented in the hospital’s medical
report) is not consistent with the observed clinical manifestation.
TMS operators explicitly screen participants and are also able to
witness clinical manifestations of T-LOC during stimulation. There-
fore they have direct access to information necessary to tell the
two etiologies apart. The report in hand provides necessary infor-
mation and literature to do so and could therefore reduce false
association of T-LOC with seizure. However, if in doubt, medical
advice by a physician is to be sought. We did not consider the dif-
ferential diagnosis of cardiogenic syncope in this case report,
because it was highly unlikely (young woman; no history or family
history of cardiac disease; no sudden occurrence of syncope, that
is, ‘‘drop attack”; electrocardiography showed normal results;
among other things; also see Dohrmann and Cheitlin, 1986).
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